Weighted Average Number of Shares Outstanding, Basic of NEVRO CORP from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
NEVRO CORP quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • NEVRO CORP Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2024 was 37,088,476, a 3.1% increase year-over-year.
  • NEVRO CORP annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 37,088,476, a 3.1% increase from 2023.
  • NEVRO CORP annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 35,981,431, a 1.9% increase from 2022.
  • NEVRO CORP annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 35,317,644, a 1.4% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

NEVRO CORP Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 37,088,476 +1,107,045 +3.1% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
Q3 2024 37,324,907 +1,182,652 +3.3% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 36,936,867 +1,015,328 +2.8% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 36,467,371 +882,686 +2.5% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 35,981,431 +663,787 +1.9% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 36,142,255 +740,169 +2.1% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 35,921,539 +603,773 +1.7% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 35,584,685 +510,823 +1.5% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 35,317,644 01 Oct 2022 31 Dec 2022 10-K 04 Mar 2025 2024 FY
Q3 2022 35,402,086 +523,643 +1.5% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 35,317,766 +509,377 +1.5% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023 2023 Q2
Q1 2022 35,073,862 01 Jan 2022 31 Mar 2022 10-Q 26 Apr 2023 2023 Q1
Q3 2021 34,878,443 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 34,808,389 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q4 2018 30,051,961 +627,601 +2.1% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2020 2019 FY
Q3 2018 30,123,188 +609,346 +2.1% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 30,028,985 +677,448 +2.3% 01 Apr 2018 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 29,836,277 +675,666 +2.3% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q4 2017 29,424,360 +932,269 +3.3% 01 Oct 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
Q3 2017 29,513,842 +966,053 +3.4% 01 Jul 2017 30 Sep 2017 10-Q 05 Nov 2018 2018 Q3
Q2 2017 29,351,537 +961,567 +3.4% 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018 2018 Q2
Q1 2017 29,160,611 +953,750 +3.4% 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018 2018 Q1
Q4 2016 28,492,091 +1,888,579 +7.1% 01 Oct 2016 31 Dec 2016 10-K 21 Feb 2019 2018 FY
Q3 2016 28,547,789 +666,487 +2.4% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017 2017 Q3
Q2 2016 28,389,970 +2,802,254 +11% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q1 2016 28,206,861 +3,330,478 +13% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q1
Q4 2015 26,603,512 +22,116,943 +493% 01 Oct 2015 31 Dec 2015 10-K 22 Feb 2018 2017 FY
Q3 2015 27,881,302 +26,509,091 +1932% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2016 Q3
Q2 2015 25,587,716 +24,389,024 +2035% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q1 2015 24,876,383 +23,752,700 +2114% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q4 2014 4,486,569 01 Oct 2014 31 Dec 2014 10-K 23 Feb 2017 2016 FY
Q3 2014 1,372,211 +279,026 +26% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q2 2014 1,198,692 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 1,123,683 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q3 2013 1,093,185 01 Jul 2013 30 Sep 2013 10-Q 02 Dec 2014 2014 Q3

NEVRO CORP Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 37,088,476 +1,107,045 +3.1% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
2023 35,981,431 +663,787 +1.9% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 35,317,644 +494,386 +1.4% 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2025 2024 FY
2021 34,823,258 +1,145,617 +3.4% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
2020 33,677,641 +2,873,769 +9.3% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 30,803,872 +751,911 +2.5% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2020 2019 FY
2018 30,051,961 +627,601 +2.1% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2020 2019 FY
2017 29,424,360 +932,269 +3.3% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 28,492,091 +1,888,579 +7.1% 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019 2018 FY
2015 26,603,512 +22,116,943 +493% 01 Jan 2015 31 Dec 2015 10-K 22 Feb 2018 2017 FY
2014 4,486,569 +3,395,838 +311% 01 Jan 2014 31 Dec 2014 10-K 23 Feb 2017 2016 FY
2013 1,090,731 +187,989 +21% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 902,742 01 Jan 2012 31 Dec 2012 10-K 18 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.